| P2093 | author name string | Ahmet Ziya Balta | |
| | Mehmet Levhi Akin | |
| | Sezai Demirbaş | |
| | Dursun Özgür Karakaş | |
| | Özgür Dandin | |
| | Ergün Yücel | |
| | Apdullah Haholu | |
| | Sevim Özdemir | |
| P2860 | cites work | Biological role of lactoferrin | Q24678066 |
| | Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease | Q24685692 |
| | A meta-analysis of probiotic efficacy for gastrointestinal diseases | Q31057363 |
| | Histopathological comparison of topical therapy modalities for acute radiation proctitis in an experimental rat model | Q33867039 |
| | Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy | Q33924822 |
| | Pre-, pro- and synbiotics. | Q34436976 |
| | Probiotics: potential pharmaceutical applications | Q34501914 |
| | A rat model for radiation-induced proctitis | Q34657218 |
| | Probiotics in clinical conditions | Q34665500 |
| | Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease | Q34792495 |
| | Probiotic use in children | Q35581031 |
| | Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. | Q35939274 |
| | Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease | Q37352180 |
| | Probiotic therapy in radiation-induced intestinal injury and repair | Q37524272 |
| | Radiation proctitis: a decade's experience. | Q37761060 |
| | Fecal markers: calprotectin and lactoferrin | Q38002436 |
| | Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development | Q40094901 |
| | Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer | Q42248178 |
| | Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix | Q45026616 |
| | Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers | Q45151583 |
| | Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients | Q46649727 |
| | Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings | Q46965975 |
| | Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. | Q47965260 |
| | Radiation proctitis in the rat. Sequential changes and effects of anti-inflammatory agents | Q67927300 |
| | Proctitis cystica profunda and radiation fibrosis in the rectum of the female Wistar rat after X irradiation: a histopathological study | Q70485325 |
| | The management of radiation proctitis | Q71979934 |
| | Radiation-induced proctosigmoiditis | Q72551409 |
| | A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment | Q79667669 |
| | Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy | Q80464486 |
| P433 | issue | Suppl 2 | |
| P921 | main subject | 4-aminosalicylic acid | Q229924 |
| | Lactobacillus rhamnosus | Q1607640 |
| | probiotics | Q1816730 |
| | Radiation proctitis | Q7280363 |
| P304 | page(s) | 563-569 | |
| P577 | publication date | 2013-05-05 | |
| P1433 | published in | Indian journal of surgery Association of Surgeons of India | Q26841861 |
| P1476 | title | The Efficacy of Probiotic (Lactobacillus rhamnosus GG) and 5-ASA (Aminosalicylic Acid) in the Treatment of Experimental Radiation Proctitis in Rats | |
| P478 | volume | 77 | |